The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 15.27

Cancer of the Lung And Bronchus (Invasive)

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2017
By Race/Ethnicity, Sex and Years Since Diagnosis

Race/Ethnicity Sex Years Since Diagnosis Completee
0 to 5 >5 to 10 >10 to 15 >15 to 20 >20 to 25 <=25b >25d
All Races Both Sexes 309,999 109,572 54,256 28,332 14,971 517,130 41,120 558,250
Males 141,510 45,588 21,736 11,364 6,138 226,337 21,765 248,102
Females 168,488 63,984 32,519 16,968 8,833 290,793 19,355 310,148
White Both Sexes 258,339 93,440 46,822 24,613 12,939 436,153 24,670 460,823
Males 116,834 38,583 18,374 9,649 5,184 188,624 11,651 200,275
Females 141,505 54,857 28,448 14,964 7,755 247,530 13,019 260,548
Black Both Sexes 36,049 11,452 5,411 2,605 1,499 57,017 2,802 59,819
Males 17,097 4,951 2,443 1,198 686 26,375 1,431 27,806
Females 18,952 6,501 2,968 1,407 813 30,642 1,371 32,013
Asian/
Pacific
Islander		 Both Sexes 12,447 3,592 1,679 846 379 18,944 + +
Males 6,106 1,598 791 397 192 9,084 + +
Females 6,341 1,994 889 450 187 9,860 + +
Hispanic Both Sexes 14,069 4,565 2,209 1,153 581 22,577 + +
Males 6,217 1,853 926 451 244 9,692 + +
Females 7,852 2,712 1,282 702 337 12,885 + +

Estimated prevalence percent a on January 1, 2017, of the SEER population diagnosed in the previous 25 years
By Age at Prevalence, Race/Ethnicity and Sex

Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedc
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races Both Sexes 0.1596 0.0004 0.0004 0.0020 0.0066 0.0250 0.1250 0.3820 0.8972 0.9877 0.1332
Males 0.1418 0.0003 0.0005 0.0017 0.0059 0.0216 0.1058 0.3676 0.8840 1.0532 0.1308
Females 0.1768 0.0004 0.0003 0.0022 0.0072 0.0285 0.1434 0.3950 0.9082 0.9470 0.1361
White Both Sexes 0.1724 0.0003 0.0005 0.0021 0.0069 0.0250 0.1196 0.3744 0.9105 1.0089 0.1336
Males 0.1504 0.0002 0.0006 0.0016 0.0061 0.0211 0.0990 0.3515 0.8760 1.0544 0.1284
Females 0.1939 0.0004 0.0004 0.0026 0.0077 0.0291 0.1398 0.3956 0.9400 0.9801 0.1389
Black Both Sexes 0.1252 0.0007 0.0003 0.0017 0.0051 0.0249 0.1695 0.4765 0.9086 0.8480 0.1408
Males 0.1207 0.0008 0.0005 0.0023 0.0055 0.0248 0.1530 0.5204 1.0559 1.0662 0.1584
Females 0.1294 0.0005 - 0.0012 0.0046 0.0249 0.1839 0.4414 0.8056 0.7391 0.1300
Asian/
Pacific
Islander		 Both Sexes 0.0908 - - 0.0012 0.0056 0.0238 0.0995 0.2915 0.6085 0.7913 0.0997
Males 0.0909 - - 0.0013 0.0038 0.0200 0.0972 0.3137 0.6950 0.9516 0.1109
Females 0.0908 - - 0.0010 0.0072 0.0271 0.1016 0.2737 0.5393 0.6868 0.0917
Hispanic Both Sexes 0.0388 0.0001 0.0002 0.0015 0.0042 0.0131 0.0543 0.1617 0.4417 0.5334 0.0653
Males 0.0330 0.0001 0.0002 0.0011 0.0031 0.0109 0.0454 0.1456 0.4429 0.6119 0.0655
Females 0.0448 0.0002 0.0002 0.0019 0.0054 0.0154 0.0631 0.1760 0.4408 0.4847 0.0661

Footnotes:

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the Alaska Native Registry) and 1/1/2017 US population estimates based on the average of 2016 and 2017 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years.

b Maximum limited-duration prevalence is 25 years for 1992-2017 data.

c Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

d Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

e Complete prevalence is obtained by summing <=25 and >25.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.